Thread by @WHO

Today, 2 versions of the AstraZeneca/Oxford #COVID19 vaccine are listed for emergency use, giving the green light for these vaccines to be rolled out globally through #COVAX. The vaccines are produced by AstraZeneca-SKBio 🇰🇷 & the Serum Institute of 🇮🇳

👉bit.ly/3rQJMKM

As part of the Emergency Use Listing, WHO assessed the quality, safety and efficacy data, risk management plans and programmatic suitability, such as cold chain requirements of the AstraZeneca/Oxford #COVID19 vaccine.

👉bit.ly/3rQJMKM

The vaccine was reviewed by WHO’s Strategic Advisory Group of Experts on Immunization (SAGE), which makes recommendations for vaccines’ use in populations. The SAGE recommended the AstraZeneca/Oxford #COVID19 vaccine for all age groups 18 & above.

👉bit.ly/3rQJMKM

Once #COVAX starts roll-out, more countries will be able to vaccinate their health workforce and people at risk of severe disease. The aim is to increase access in all countries to stem the #COVID19 pandemic

👉bit.ly/3rQJMKM

"Announcement of two vaccine versions of AstraZeneca allows everybody to access #COVID19 vaccines. Experts have looked at this vaccine and it is safe, of good quality and is effective"-Deusdedit Mubangizi, WHO Prequalification Unit Head

#VaccinEquity #ACTogether